Your browser doesn't support javascript.
loading
Translation control of the immune checkpoint in cancer and its therapeutic targeting.
Xu, Yichen; Poggio, Mauro; Jin, Hyun Yong; Shi, Zhen; Forester, Craig M; Wang, Ying; Stumpf, Craig R; Xue, Lingru; Devericks, Emily; So, Lomon; Nguyen, Hao G; Griselin, Alice; Gordan, John D; Umetsu, Sarah E; Reich, Siegfried H; Worland, Stephen T; Asthana, Saurabh; Barna, Maria; Webster, Kevin R; Cunningham, John T; Ruggero, Davide.
Afiliação
  • Xu Y; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
  • Poggio M; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Jin HY; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
  • Shi Z; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Forester CM; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
  • Wang Y; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Stumpf CR; Department of Developmental Biology, Stanford University, Stanford, CA, USA.
  • Xue L; Department of Genetics, Stanford University, Stanford, CA, USA.
  • Devericks E; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
  • So L; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Nguyen HG; Division of Pediatric Allergy, Immunology & Bone Marrow Transplantation, University of California, San Francisco, San Francisco, CA, USA.
  • Griselin A; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
  • Gordan JD; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Umetsu SE; State Key Laboratory of Pharmaceutical Biotechnology, Nanjing Advanced Institute for Life Sciences, School of Life Sciences, Nanjing University, Nanjing, Jiangsu, China.
  • Reich SH; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
  • Worland ST; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Asthana S; eFFECTOR Therapeutics, San Diego, CA, USA.
  • Barna M; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
  • Webster KR; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
  • Cunningham JT; Department of Urology, University of California, San Francisco, San Francisco, CA, USA.
  • Ruggero D; Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
Nat Med ; 25(2): 301-311, 2019 02.
Article em En | MEDLINE | ID: mdl-30643286
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biossíntese de Proteínas / Imunoterapia / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Biossíntese de Proteínas / Imunoterapia / Neoplasias Hepáticas Tipo de estudo: Prognostic_studies Limite: Animals Idioma: En Revista: Nat Med Assunto da revista: BIOLOGIA MOLECULAR / MEDICINA Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos